missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Cytiva Capto™ L Chromatography Medium
Capto L is a BioProcess chromatography medium (resin) for the capture of antibodies and antibody fragments.
$1285.44 - $8077.23
Specifications
| Product Type | Capto L chromato graphy media |
|---|---|
| Height (English) | 7.87 in. |
| Height (Metric) | 200mm |
| Flow Rate | <500 cm/hr. |
| Ligand Type | Recombinant Protein L (E. coli), mammalian free |
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
|
45-002-603
|
Cytiva
17547806 |
5 mL |
Each for $1,285.44
|
|
|||||
|
45-002-601
|
Cytiva
17547801 |
25 mL |
Each for $2,021.00
|
|
|||||
|
09928076
|
Cytiva
17547802 |
200 mL |
Each for $8,077.23
|
|
|||||
Description
Capto L is suitable for the capture of a wide range of antibody fragments such as Fabs, single-chain variable fragments (scFv), and domain antibodies (Dabs).
- High binding capacity, low ligand leakage, and selectivity for a broad range of antibody fragments reduces process time and amount of medium.
- Enables a platform approach for purification of antibody fragments.
- Increased productivity, process economy, and process design flexibility due to rigid matrix.
- The high binding capacity and selectivity for a broad range of antibody fragments makes Capto L an excellent capture platform for antibody fragments containing kappa light chains.
- Using Capto L requires minimal optimization and it produces high purity in one separation step.
- Capto L provides several advantages in manufacturing processes because the high selectivity of affinity capture reduces the number of subsequent polishing steps.
Specifications
| Capto L chromato graphy media | |
| 200mm | |
| Recombinant Protein L (E. coli), mammalian free | |
| 85μm | |
| 2° to 8°C |
| 7.87 in. | |
| <500 cm/hr. | |
| 2 to 10 | |
| Highly Cross-linked Agarose | |
| High binding capacity, low ligand leakage and selectivity for a broad range of Antibody fragments reduces process time and amount of medium |